PACE: A Pivotal Phase 2 Trial of Ponatinib in Patients With...

Clinical Lymphoma Myeloma and Leukemia 2013 / 09 Vol. 13

PACE: A Pivotal Phase 2 Trial of Ponatinib in Patients With CML and Ph+ ALL Resistant or Intolerant to Dasatinib or Nilotinib, or With the T315I Mutation

Cortes, Jorge E., Kim, Dong-Wook, Pinilla, Javier, Paquette, Ronald, le Coutre, Philipp D., Chuah, Charles, Nicolini, Franck E., Apperley, Jane F., Jean Khoury, H., Talpaz, Moshe, DiPersio, John F., D
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2013.07.098
Date:
September, 2013
File:
PDF, 65 KB
english, 2013
Conversion to is in progress
Conversion to is failed